Pharma

hand over keys buy house gift takeover acquisition
Pharma

ANI offers $560M to buy out rare disease pharma Egetis

ANI is poised to buyout Egetis Therapeutics and its lead asset Emcitate, the first and only approved treatment for MCT8 deficiency.
Donavyn Coffey Nov 5, 2026 11:35am
Splash celebration glitter

$200M in 5 weeks: Behind RevMed's 'eye-popping' Rasonque debut

Nov 5, 2026 11:11am
Resource Icon
The direct-to-patient DTP market is full of providers making bold claims But claims are not outcomes To unlock the true p

DTP – Delivering Proof Over Promise

Brought to you by Gifthealth
MA

AZ’s reported $10B offer for Rhythm fuels talks of a bidding war

Nov 5, 2026 9:36am
Podcast
How AI turns field conversations into actionable insights

How AI turns field conversations into actionable insights

Brought to you by Inizio Ignite
Yvonne Greenstreet Alnylam

Alnylam seeks new commercial lead as Tanguler hits the exit

Nov 5, 2026 7:13am